Fizazi, A., Serrand, C., Evrard, A., Bergeret, B., Stoebner, P.-E., & Marque, M. (2024). High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors. Acta Dermato-Venereologica, 104, adv40913. https://doi.org/10.2340/actadv.v104.40913